Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine for diabetic macular edema
RBR-87b6r5sPhase 2Completed
- Sponsor
- Federal University of São Paulo
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic macular edema (DME) and diabetic retinopathy (DR) comparing Lamivudine + bevacizumab with Placebo + bevacizumab (2 arms). Started Feb 2022; status: completed.
02
Drugs
lamivudine
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on RBR-87b6r5s.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-87b6r5s.